首页> 外国专利> Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter

Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter

机译：决奈达隆在制备用于预防首次发生房颤或房扑的患者的心血管疾病住院或死亡中的药物的用途

页面导航

摘要
著录项
相似文献

摘要

Use of dronedarone or pharmaceutically acceptable salts thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter.

机译：决奈达隆或其药学上可接受的盐在制备药物中的用途，所述药物用于预防心房颤动或房扑首次复发的心血管疾病的住院或死亡。

著录项

公开/公告号EP2386300A1

专利类型
公开/公告日2011-11-16

原文格式PDF
申请/专利权人 SANOFI;
展开▼

申请/专利号EP20100305504
发明设计人 THE DESIGNATION OF THE INVENTOR HAS NOT YET BEEN FILED;
展开▼

申请日2010-05-11
分类号A61K31/343;A61P9;
国家 EP
入库时间 2022-08-21 17:14:50

相似文献

专利
外文文献
中文文献